Wilms' tumour, or nephroblastoma, accounts for approximately 5% of all malignant disease in childhood, according to figures from the Manchester Children's Tumour Registry (Marsden and Steward, 1968) . Its mode of spread is usually direct to adjacent structures, and via lymph and blood-stream to lymph nodes, liver, and lungs. After the initial surgical excision of the tumour together with any affected adjacent structures and lymph nodes, the commonest site for recurrence is in the lungs. In many children the recurrence is confined to the lungs, and it is the management and prognosis of this particular group of children that we wish to discuss.
On reviewing the larger series of children with Wilms' tumour in the literature, small numbers of patients have been described where pulmonary metastases have been successfully treated (Swenson, 1969; Snyder, Hastings, and Pollock, 1969; Johnson, Maceira, and Koop, 1967) . A variety of methods has been employed; radiotherapy, surgery, chemotherapy, and various combinations of these. However, in a recent major textbook of paediatric urology the comment is made, 'late recurrences in the lungs have been treated . . . but with relatively little success' (Williams, 1968) . We wish to describe our experiences in Liverpool to illustrate that such a view is too gloomy.
At Alder Hey Hospital and the Royal Liverpool Children's Hospital over a 21-year period from 1948-1968, 63 children with Wilms' tumour were seen. This group is believed to be all but 2 of the cases that occurred in the Liverpool area in this period. Of these 63 children, 16 patients, that is 1 in 4, were treated at some stage of their illness for metastases confined to the lungs. The ages of these 16 children ranged from 11 months to 11 years, and 14 of the 16 were aged 5 years or less: 9 were girls and 7 boys. 14 of the 16 children had initial surgical excision of their abdominal tumour via the transabdominal approach, with early ligation of the renal vessels, followed by radiotherapy to their *Communication given to the Annual Meeting of the British Paediatric Association, Scarborough, 1970. abdomen. The radiated field was usually the hemi-abdomen but crossing the spine to prevent asymmetrical growth. 2 children had radiotherapy before surgical excision.
Results
In one child pulmonary secondaries were present at the time of diagnosis, in 11 they occurred within 6 months of diagnosis, and in all but one case metastases developed within one year. The 16 children had their lung recurrences treated in two principal ways.
(1) The larger group of 11 children received radiotherapy to their lung fields ( Table I ). The policy was to irradiate both fields regardless of the site(s) of the metastases. High voltage machines were used and total doses ranged from 1200-3400 roentgen (usually about 2500 roentgen). In addition actinomycin D was given in 4 children treated later in the series. Died 5 The results of treatment in these 11 children were as follows: 4 are alive and well 2, 9, 15, and 21 years later; 1 of these children had a malignant effusion accompanying her pulmonary metastases, and another child had a mediastinal secondary which was irradiated; it recurred 6 months later, was irradiated again, and she is now well, over 2 years later. 7 children died; of these 3 died within 3 months of completing their radiotherapy and at post-mortem examination there was no evidence of malignancy but only of fibrosis and infection. These 3 children received 2950, 2800, and 3400 roentgen, respectively, and none of them was given actinomycin D which is known to potentiate the effects of radiotherapy on the lungs. They were all treated early in the series. The other 4 children who died all developed further lung metastases and died 4, 5, 7, and 8 months later.
(2) In a smaller group of 5 children surgical excision of the pulmonary metastases was performed ( Table II) . 3 of these children had a solitary pulmonary metastasis excised, but in the other 2 metastases were present in more than one lobe. In the first of these, wedge resections were performed in the right upper and right lower lobes at the same operation, and in the second child a wedge resection of a metastasis in the left upper lobe was followed a week later by removal of the right lower lobe which contained a further metastasis. Of this group, 3 children received actinomycin D, in 2 cases, a single course at the time of operation, and in the other case, 4 courses over a period of one year starting at the time of operation. 3 of these 5 children are alive and free of disease 19 months, 4 years, and 11 years later. The 2 children who died survived 13 and 15 months from the time of their lung resection, and both developed further lung metastases. Since 1960 in addition to either operation or radiotherapy we have given actinomycin D. At first this drug was given either at the time or shortly after the initial therapy in a single course, but in the last 2 patients repeated courses at 4-monthly intervals over a year have been given. There is a considerable amount of published material confirming the usefulness of this drug, and in addition there is now good evidence from the American Cancer Study Group A among others that repeated courses are more effective than a single course (Wolff et al., 1968 
Sputum Viscosity and Pulmonary Function in Cystic Fibrosis
The development of the pulmonary lesions in cystic fibrosis (CF) has been attributed to obstruction of the airways by abnormally viscous mucus (Farber, 1944) . We have examined the relation between sputum viscosity and pulmonary function in CF.
Patients and Methods
The patients studied ( Table) were described in a previous publication (Feather and Russell, 1970a) . Of a total of 30 patients with CF in the North-Eastern Hospital Region of Scotland, only the 5 described regularly produced sputum. During the period of study patients were in a clinically stable phase of their illness and their usual therapy remained unchanged. The sputum specimens studied were expectorated spontaneously during the first hour after waking; no means ofliquefying the sputumwas used before expectorating the samples. Apparent viscosity at 900 sec.~' of each sputum sample was measured within two hours of expectoration on a cone and plate viscometer, as described elsewhere (Feather and Russell, 1970a) . A significant correlation has been shown between this and other measures of sputum viscosity in these patients (Feather and Russell, 1970b) .
The forced expiratory volume in one second (FEV1.0) and forced vital capacity (FVC) were measured by means of a dry spirometer.* On each occasion the best of three measurements taken before, and the best of three taken after the inhalation of isoprenaline were recorded. To avoid the inclusion of any reversible airways obstruction (present at times in all the patients studied) the 'over-all best' (i.e. before or after the inhalation of isoprenaline) FEV1.0 and FVC were recorded. All volumes were converted to BTPS and expressed as a percentage of the predicted value. Predicted values were obtained from the data of Strang (1959) supplemented for the FVC of Case 3 by those of Lunn (1965) .
Results were obtained during the control period for the trial of tolazoline, previously reported (Feather and Russell, 1970a) . Sputum viscosity was measured on the same day and as close in time as possible to lung volume measurements. Measurements were made on days 4 and 7 of each week. The data for the Fig. were obtained during week 1.
To examine the relation between day-to-day changes in sputum viscosity and changes in pulmonary function, these measurements made on the same day during the period of observation were compared. Because tolazoline had no demonstrable effect on either sputum viscosity or respiratory function, results obtained during the four weeks of observation were pooled.
Results
The Fig. shows 
